On the morning of August 19, 2024, our company held a mid year work summary and commendation meeting for 2024. Huang Shenghong, Chairman and President of the company, Dr. Yuan Chengguang, Senior Vice President and Chief Scientist, Yao Renchong, Senior Vice President, and all employees attended the meeting.
At the beginning of the meeting, Chairman and President Huang Shenghong delivered a speech, sharing the impressive progress made by Sungening Biotechnology in the first half of 2024, especially the milestone event of the IND approval of the innovative drug SG1001 oral tablet in the second quarter of 2024. He also quickly reached a strategic cooperation with Lizhu Pharmaceutical and signed a Greater China equity transaction agreement. Looking back at the two "8 years" of the development of the Sungening Biotechnology brand, we have achieved strategic breakthroughs in three stages, accumulated and developed steadily, and jointly look forward to the third "8 years" of innovative drug layout, demonstrating the company's ambition and expectations for the future.
Speech by Chairman and President Huang Shenghong
Finally, the management will recognize and promote members who have made significant contributions to the team in the first half of 2024. Senior Vice President Yao Ren rushed to all colleagues to announce the promotion and appointment announcement, and congratulated and motivated them. Dr. Yuan Chengguang emphasized the work achievements of the promoted personnel and the important role they played in team collaboration. Subsequently, colleagues who received promotions and commendations shared their work summaries and feelings for the first half of 2024, demonstrating the cohesion and centripetal force of the Sungening Biotechnology team.
Dr. Yuan Chengguang, Senior Vice President and Chief Scientist, delivered a speech
On the morning of August 19, 2024, our company held a mid year work summary and commendation meeting for 2024. Huang Shenghong, Chairman and President of the company, Dr. Yuan Chengguang, Senior Vice President and Chief Scientist, Yao Renchong, Senior Vice President, and all employees attended the meeting.
Promotion&Appointment Photo
Although the mid year work summary and commendation meeting of Sungening Biotechnology in 2024 is brief, it is of great significance for team building and company development, and the management attaches great importance to it. Review and summarize, never forget the original intention, look forward to the future, and forge ahead!
